APA (7th ed.) Citation

Tiraboschi, G., Papp, K., Bieber, T., Weidinger, S., Beck, L., Lee, C., . . . Hurbin, F. (2025). Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis. CPT: Pharmacometrics & Systems Pharmacology, 14(12), 2161. https://doi.org/10.1002/psp4.70121

Chicago Style (17th ed.) Citation

Tiraboschi, Gilles, et al. "Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis." CPT: Pharmacometrics & Systems Pharmacology 14, no. 12 (2025): 2161. https://doi.org/10.1002/psp4.70121.

MLA (9th ed.) Citation

Tiraboschi, Gilles, et al. "Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis." CPT: Pharmacometrics & Systems Pharmacology, vol. 14, no. 12, 2025, p. 2161, https://doi.org/10.1002/psp4.70121.